145 related articles for article (PubMed ID: 32487848)
21. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
[TBL] [Abstract][Full Text] [Related]
22. Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy.
Wong CAC; Wong SAY; Leitch HA
Leuk Res; 2018 Apr; 67():75-81. PubMed ID: 29477023
[TBL] [Abstract][Full Text] [Related]
23. Multiple red blood cell transfusions and iron overload in very low birthweight infants.
Treviño-Báez JD; Briones-Lara E; Alamillo-Velázquez J; Martínez-Moreno MI
Vox Sang; 2017 Jul; 112(5):453-458. PubMed ID: 28516443
[TBL] [Abstract][Full Text] [Related]
24. Glycosylated ferritin as an improved marker for post-transfusion iron overload.
Ishihara A; Yamauchi T; Ikeda K; Fukuyoshi Y; Yokoyama T; Yonemura Y; Uchiba M; Matsui H
Int J Hematol; 2021 Apr; 113(4):537-546. PubMed ID: 33400141
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes.
Cazzola M; Della Porta MG; Malcovati L
Hematology Am Soc Hematol Educ Program; 2008; ():166-75. PubMed ID: 19074076
[TBL] [Abstract][Full Text] [Related]
26. Impact of transfusion on survival in patients with myelodysplastic syndromes: Current knowledge, new insights and transfusion clinical practice.
Kaphan E; Laurin D; Lafeuillade B; Drillat P; Park S
Blood Rev; 2020 May; 41():100649. PubMed ID: 31918886
[TBL] [Abstract][Full Text] [Related]
27. Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?
Leitch HA; Vickars LM
Hematology Am Soc Hematol Educ Program; 2009; ():664-72. PubMed ID: 20008252
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Iron Overload in Patients with Acute Leukemia and Myelodysplastic Syndrome on Hepatic and Endocrine functions.
Yassin MA; Soliman A; De Sanctis V; Hmissi SM; Abdulla MAJ; Ekeibed Y; Ismail O; Nashwan A; Soliman D; Almusharaf M; Hussein R
Acta Biomed; 2018 Apr; 89(3-S):18-22. PubMed ID: 29633728
[TBL] [Abstract][Full Text] [Related]
29. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
[TBL] [Abstract][Full Text] [Related]
30. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Delforge M; Selleslag D; Triffet A; Mineur P; Bries G; Graux C; Trullemans F; MacDonald K; Abraham I; Pluymers W; Ravoet C
Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
[TBL] [Abstract][Full Text] [Related]
31. Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy.
Sait S; Zaghloul N; Patel A; Shah T; Iacobas I; Calderwood S
Pediatr Blood Cancer; 2014 Dec; 61(12):2319-20. PubMed ID: 25154390
[TBL] [Abstract][Full Text] [Related]
32. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
33. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.
Wermke M; Schmidt A; Middeke JM; Sockel K; von Bonin M; Schönefeldt C; Mair S; Plodeck V; Laniado M; Weiss G; Schetelig J; Ehninger G; Theurl I; Bornhäuser M; Platzbecker U
Clin Cancer Res; 2012 Dec; 18(23):6460-8. PubMed ID: 22991415
[TBL] [Abstract][Full Text] [Related]
34. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
35. Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study.
Nolte F; Nückel H; Schmidt B; Geer T; Rubanov O; Hebart H; Jarisch A; Albrecht S; Johr C; Schumann C; Hofmann WK
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1531-1538. PubMed ID: 29761371
[TBL] [Abstract][Full Text] [Related]
36. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
[TBL] [Abstract][Full Text] [Related]
37. Characterization of transfusion-derived iron deposition in childhood cancer survivors.
Ruccione KS; Wood JC; Sposto R; Malvar J; Chen C; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1913-9. PubMed ID: 24962841
[TBL] [Abstract][Full Text] [Related]
38. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
Malcovati L
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858
[TBL] [Abstract][Full Text] [Related]
39. The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients.
Xhaard A; Miekoutima E; Pirenne F; François A; Tiberghien P; Sebert M; Adès L; Fenaux P; Leprêtre AC
Vox Sang; 2022 May; 117(5):693-700. PubMed ID: 34985763
[TBL] [Abstract][Full Text] [Related]
40. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions.
Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB
Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
